Breast Cancer Multidisciplinary Team Adjuvant Therapy Decision Making and Adjuvant! Online

Clinical Oncology

Volumn 22, Issue 1, 2010, Pages 87-88

  Nowak, V ^a   Ah See, M ^a   Ravichandran, D ^a  

^a BEDFORD HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; TAMOXIFEN;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER RISK; CANCER SURVIVAL; DRUG UTILIZATION; HORMONAL THERAPY; HUMAN; LETTER; MEDICAL DECISION MAKING; ONLINE SYSTEM; PATIENT SELECTION; PRIORITY JOURNAL; RISK REDUCTION; TEAMWORK;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DECISION MAKING, COMPUTER-ASSISTED; FEMALE; HUMANS; PATIENT CARE TEAM;

EID: 73149087030     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2009.11.002     Document Type: Letter

References (5)

1. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365 (2005) 1687-1717
2. Williams C., Brunskill S., Altman D., et al. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy. Health Technol Assess 10 34 (2006) 69-89
3. Munoz M., Estevez L.G., Alvarez I., et al. Evaluation of international treatment guidelines and prognostic tests for the treatment of early breast cancer. Cancer Treat Rev 34 (2008) 701-709
4. Avaliable at:. http://www.nice.org.uk/nicemedia/pdf/CG80NICEGuideline.pdf
5. Avaliable at:. www.nice.org.uk/TA112